Third Dose of Pfizer/BioNTech Covid-19 vaccine 95.6% Effective: Study

The clinical phase three trial involved 10,000 participants 16 years of age and older.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.